Literature DB >> 18426387

Current and future testosterone delivery systems for treatment of the hypogonadal male.

Emily Pfeil1, Adrian S Dobs.   

Abstract

BACKGROUND: Hypogonadism is manifest in all age groups, and a growing elderly population is requiring treatment for testosterone deficiency, presenting new safety challenges, as many of these individuals present with comorbidities and significant risk profiles.
OBJECTIVE: To discuss testosterone replacement modalities, their advantages and disadvantages, and provide a discussion of safety issues.
METHODS: We reviewed the literature regarding testosterone replacement therapy and have provided a summary of our most outstanding findings.
CONCLUSION: Potential benefits of testosterone replacement therapy include increased lean body mass, heightened libido, increased bone density and elevation of mood. Some disadvantages are clearly defined, while others require further investigation. Patient and physician must cooperate to agree on an individual patient's most appropriate and tolerable route of administration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426387     DOI: 10.1517/17425247.5.4.471

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  13 in total

Review 1.  Novel Therapy for Male Hypogonadism.

Authors:  Robert Carrasquillo; Kevin Chu; Ranjith Ramasamy
Journal:  Curr Urol Rep       Date:  2018-06-09       Impact factor: 3.092

2.  An update on male hypogonadism therapy.

Authors:  Prasanth Surampudi; Ronald S Swerdloff; Christina Wang
Journal:  Expert Opin Pharmacother       Date:  2014-04-23       Impact factor: 3.889

Review 3.  The role of testosterone in erectile dysfunction.

Authors:  Giovanni Corona; Mario Maggi
Journal:  Nat Rev Urol       Date:  2009-12-08       Impact factor: 14.432

Review 4.  Topical testosterone supplementation for the treatment of male hypogonadism.

Authors:  Katrina A Abadilla; Adrian S Dobs
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

5.  Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option.

Authors:  Maria Gabriela Figueiredo; Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  J Clin Endocrinol Metab       Date:  2022-02-17       Impact factor: 5.958

6.  Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

Authors:  Prasanth N Surampudi; Christina Wang; Ronald Swerdloff
Journal:  Int J Endocrinol       Date:  2012-03-14       Impact factor: 3.257

7.  Direct Reprogramming of Mouse Fibroblasts toward Leydig-like Cells by Defined Factors.

Authors:  Yan Yang; Ziyi Li; Xupeng Wu; Haolin Chen; Wenting Xu; Qi Xiang; Qihao Zhang; Jie Chen; Ren-Shan Ge; Zhijian Su; Yadong Huang
Journal:  Stem Cell Reports       Date:  2016-12-22       Impact factor: 7.765

8.  Induced pluripotent stem cell-derived conditional medium promotes Leydig cell anti-apoptosis and proliferation via autophagy and Wnt/β-catenin pathway.

Authors:  Xiaoling Guo; Yong Chen; Tingting Hong; Xianwu Chen; Yue Duan; Chao Li; Renshan Ge
Journal:  J Cell Mol Med       Date:  2018-04-18       Impact factor: 5.310

9.  Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single-Use Autoinjector: A Phase II Study.

Authors:  Jed Kaminetsky; Jonathan S Jaffe; Ronald S Swerdloff
Journal:  Sex Med       Date:  2015-09-17       Impact factor: 2.491

Review 10.  Diagnosis and management of testosterone deficiency.

Authors:  James A McBride; Culley C Carson; Robert M Coward
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.